Category
Conflicts of interest
-
•
Prescribing data and the side effects of assumptions #ahcj14
Reporters curious about the financial relationship between physicians and pharmaceutical companies can use publicly available data as a starting point…
-
Reporter looks at why, how clinic banned drug reps and their samples
Six years ago, a clinic in Oregon made the decision to ban representatives from the pharmaceutical companies. The doctors and…
-
Independent reviews find less benefit, more harm than first reported for bone protein product
Efforts to correct biased and dangerous medical studies are making more headlines. Shortly after I posted about a new idea…
-
When disease charities partner with drug companies, where does that leave patients (and reporters)?
A few weeks ago, I reached out to a disease charity for comment on a story I was working on.…
-
•
Using data to track doctors’ referrals, relationships #ahcj13
Going online is usually a great way to waste time or — for adventurous social media users — get in…
-
•
Pharmaceutical industry influence starts with the doctor’s prescribing pen #ahcj13
Can a doctor’s prescription be bought for a tuna sandwich? Whether it’s a tuna sandwich, steak dinner or a four-figure…
-
•
Panel will discuss newly released 990 data on hospitals #ahcj13
AHCJ has just released a new trove of information from GuideStar on the finances of nonprofit U.S. hospitals. This information –…
-
•
Even in treatment guidelines, pharma conflicts abound
As part of the ongoing Milwaukee Journal Sentinel and MedPage Today series “Side Effects” John Fauber and Ellen Gabler “examined…
-
•
Investigation: Medtronic paid millions to surgeons; ghostwrote papers
Over at the Milwaukee Journal Sentinel and MedPage Today, John Fauber updates Side Effects, his long-running investigation into conflicts of…
-
•
Reporter tracks top prescribers’ ties to drugs they prescribe
A while back, Sen. Charles Grassley wrote to state health officials, asking for lists of top Medicaid prescribers of certain…